Venom Immunotherapy

Jubilant Pharma partnered with Colormatics to raise awareness for Venom Immunotherapy (VIT)—a life-saving treatment for people allergic to bee and wasp stings. The campaign was designed to educate the public about the risks of insect venom allergies and drive more patients to seek treatment through allergists and Jubilant’s “BeeAware” platform.

Challenge

Venom allergies are a serious but often underrecognized health risk, affecting a significant portion of the population and leading to thousands of emergency room visits each year. Without treatment, severe reactions can be life-threatening. Jubilant needed a way to: Raise awareness of a complex medical treatment (VIT) Educate patients about allergy risks from stings Encourage action through allergist consultations and the BeeAware website Do all of this in a way that felt accessible and memorable, not overly clinical

Solution

Colormatics created a multi-channel awareness campaign anchored by a cinematic commercial. The creative approach included: A scripted narrative designed for broad audience understanding Casting and production built around relatable real-world scenarios Visual effects, including a memorable CGI bee, to bring the threat of venom allergy to life Supporting digital photography and ad assets for online and paid media distribution The campaign balanced education and emotion, making a complex medical topic easier to understand while keeping the message engaging and memorable.

Results

The campaign successfully increased awareness of Venom Immunotherapy and drove traffic to Jubilant’s BeeAware platform. While long-term success is tied to treatment adoption and reduced emergency incidents, the immediate impact was strong engagement and positive reception of the creative approach. The campaign helped position VIT as a more recognizable and actionable treatment option for allergy sufferers.